Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms intrastrand base pairs
Abstract
The present invention provides a recombinant adeno-associated virus (rAAV) virus preparation, which rAAV virus preparation is essentially free of other viruses, comprising an rAAV vector, wherein the rAAV vector comprises a single-stranded heterologous nucleotide sequence comprising a coding region which forms intrastrand base pairs such that expression of the coding region of the heterologous sequence is enhanced relative to an rAAV vector that lacks sufficient intrastrand base pairing to enhance said expression, wherein the rAAV vector comprises one or more inverted terminal repeat (ITR) sequences flanking said heterologous sequence, wherein the rAAV vector is less than 2.5 kilobases in length, wherein the total amount of unique sequence present in the heterologous sequence is about one-half of the heterologous sequence and wherein the heterologous sequence forms intrastrand base pairs along most or all of its length, for use in a method of treatment of the human or animalbody by therapy.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
39 members in 12 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 16008099 | United States of America | P |
Members39
| Document | Office | Kind | |
|---|---|---|---|
| CA2379166A1 | Canada | A1 | |
| WO0111034A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU6626500A | Australia | A | |
| WO0111034A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1204739A2 | European Patent Office (EPO) | A2 | |
| JP2003506083A | Japan | A | |
| US6596535B1 | United States of America | B1 | |
| US2003219735A1 | United States of America | A1 | |
| AU781958B2 | Australia | B2 | |
| AU781958C | Australia | C | |
| US7125717B2 | United States of America | B2 | |
| US2007087433A1 | United States of America | A1 | |
| EP1916258A2 | European Patent Office (EPO) | A2 | |
| EP1204739B1 | European Patent Office (EPO) | B1 | |
| AT403715TThis record | Austria | T | |
| US2008206197A1 | United States of America | A1 | |
| DE60039766D1 | Germany | D1 | |
| DK1204739T3 | Denmark | T3 | |
| PT1204739E | Portugal | E | |
| ES2308989T3 | Spain | T3 | |
| EP1916258A3 | European Patent Office (EPO) | A3 | |
| JP2010172349A | Japan | A | |
| US7785888B2 | United States of America | B2 | |
| US7846729B2 | United States of America | B2 | |
| US2011104117A1 | United States of America | A1 | |
| EP2369002A1 | European Patent Office (EPO) | A1 | |
| JP4827353B2 | Japan | B2 | |
| US8093054B2 | United States of America | B2 | |
| US2012184602A1 | United States of America | A1 | |
| CY1107432T1 | Cyprus | T1 | |
| CA2379166C | Canada | C | |
| JP5277427B2 | Japan | B2 | |
| EP1916258B1 | European Patent Office (EPO) | B1 | |
| ES2478635T3 | Spain | T3 | |
| DK1916258T3 | Denmark | T3 | |
| PT1916258E | Portugal | E | |
| US2016168589A1 | United States of America | A1 | |
| CY1115408T1 | Cyprus | T1 | |
| US2019100773A1 | United States of America | A1 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 953892
Titles2
- German
- ERHÖHUNG DER EXPRESSION EINER EINZELSTRÄNGIGEN, HETEROLOGEN NUKLEOTIDSEQUENZ VON EINEM REKOMBINANTEN VIRALEN VEKTOR DURCH AUSGESTALTUNG DER SEQUENZ IN EINER ART UND WEISE, DASS BASENPAARUNGEN INNERHALB DER SEQUENZ ENTSTEHEN
- English
- INCREASING THE EXPRESSION OF A HORIZONTAL, HETEROLOGIC NUCLEOTIDE SEQUENCE FROM A RECOMBINANT VIRAL VECTOR BY DESIGNING THE SEQUENCE IN SUCH A WAY THAT BASE COMPENSATIONS ARISE INSIDE THE SEQUENCE
Classification
- CPC, 9
- C12N15/86
- A61K38/191
- A61K48/00
- C07K14/70578
- C07K16/00
- C07K2319/30
- C07K2319/33
- C12N2750/14143
- C12P21/06
- IPC, 12
- A61K48 00
- C12N1 15
- C12N1 19
- C12N1 21
- C12N15 00
- C12N15 09
- C12N15 864
- C12N5 10
- C12N7 00
- C12Q1 02
- C12Q1 68
- C12R1 93